Home / MDWD : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MDWD make money? Does MDWD have pricing power? What's the Earnings Whisper? Will MDWD profit more as the business scales? What is MDWD's management track record? Is MDWD's current price justified?

MediWound Ltd.

$13.11 -$5.31 (-28.83%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$13.71

Day Range

$12.95$13.81

Year Range

$12.52$20.03

Market Cap

168.41M

AVG Volume

93.32K

Trailing/Forward PE

-8.19/-

PEG ratio

-26.41

Dividend Yield

Next Earnings Date

2026-11-19

Primary Exchange

NASDAQ

Revenue (USD) · TTM

MDWD Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	11.86M
26 Q1	14.48M
25 Q4	16.96M
25 Q3	20.93M
25 Q2	19.86M
25 Q1	19.21M
24 Q4	20.22M
24 Q3	19.72M
24 Q2	20.14M
24 Q1	19.85M

Net Income (USD) · TTM

MDWD Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-20.18M
26 Q1	-26.11M
25 Q4	-23.88M
25 Q3	-20.6M
25 Q2	-28.23M
25 Q1	-21.22M
24 Q4	-30.22M
24 Q3	-28.06M
24 Q2	-19.97M
24 Q1	-12.75M

Operating Income (USD) · TTM

MDWD Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-31.78M
26 Q1	-28.03M
25 Q4	-25.28M
25 Q3	-23.55M
25 Q2	-22.11M
25 Q1	-20.87M
24 Q4	-19.38M
24 Q3	-17.19M
24 Q2	-15.14M
24 Q1	-14.66M

EBITDA (USD) · TTM

MDWD EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-19M
26 Q1	-14.84M
25 Q4	-12.61M
25 Q3	-23.15M
25 Q2	-25.69M
25 Q1	-24.34M
24 Q4	-27.35M
24 Q3	-5.99M
24 Q2	-3.08M
24 Q1	2.6M

Cash Flows (USD) · TTM

MDWD Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-28.39M
26 Q1	-25.13M
25 Q4	-21.63M
25 Q3	-18.6M
25 Q2	-19.27M
25 Q1	-19.1M
24 Q4	-19.29M
24 Q3	-20.8M
24 Q2	-20.79M
24 Q1	-20.46M

EPS (USD) · TTM

MDWD EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-1.6
26 Q1	-2.26
25 Q4	-2.1
25 Q3	-1.9
25 Q2	-2.64
25 Q1	-2.09
24 Q4	-3.07
24 Q3	-2.9
24 Q2	-2.16
24 Q1	-1.38

Expenses (USD) · TTM

MDWD Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	40.15M
26 Q1	37.39M
25 Q4	33.75M
25 Q3	31.05M
25 Q2	29.54M
25 Q1	29.38M
24 Q4	28.06M
24 Q3	27.01M
24 Q2	25.89M
24 Q1	24.15M

Shares Outstanding (USD) · TTM

MDWD Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-1.3M
26 Q1	-2.16M
25 Q4	-2.36M
25 Q3	-3.27M
25 Q2	-3.57M
25 Q1	-3.47M
24 Q4	-3.14M
24 Q3	-2.61M
24 Q2	-1.88M
24 Q1	-1.58M

Employee Count

MDWD Employee Count by quarter
Period	Employee Count
2025	121
2024	111
2023	88
2022	73
2021	67
2020	65
2019	62
2018	61
2017	60
2016	54

PE Ratio

MDWD PE Ratio by quarter
Period	PE Ratio
Jul 20	16.15
Jul 20	17.02
Jul 20	15.12
Jul 20	14.5
Jul 20	13.88
Jun 20	11.04
Jun 20	11.21
Jun 20	7.91
Jun 20	8.59
May 20	8.45
May 20	8.32
May 20	10.59
May 20	10.81
May 20	10.97
Apr 20	10.42
Apr 20	10.92
Apr 20	8.78
Apr 20	8.04
Mar 20	9.05
Mar 20	8.72
Mar 20	11.57
Mar 20	13.55
Feb 20	15.2
Feb 20	4.26
Feb 20	4.25
Feb 20	4.29
Jan 20	4.33
Jan 20	4.36
Jan 20	4.33
Jan 20	4.33
Jan 20	4.36
Dec 19	4.32
Dec 19	4.34
Dec 19	4.43
Dec 19	4.09
Nov 19	4.28
Nov 19	4.29
Nov 19	4.36
Nov 19	5.01
Nov 19	4.88
Oct 19	4.65
Oct 19	4.68
Oct 19	4.98
Oct 19	5.03
Sep 19	5.15
Sep 19	5.51
Sep 19	5.36
Sep 19	5.08
Aug 19	5.26
Aug 19	5.03
Aug 19	4.53

Free Cash Flow Yield

MDWD Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-16.81%
Sep 26	-16.58%
Aug 26	-17.4%
Aug 26	-16.68%
Aug 26	-16.25%
Aug 26	-13.57%
Jul 26	-13.82%
Jul 26	-13.72%
Jul 26	-13.36%
Jul 26	-13.66%
Jul 26	-12.88%
Jun 26	-12.85%
Jun 26	-13.71%
Jun 26	-13.73%
Jun 26	-13.77%
May 26	-11.77%
May 26	-10.17%
May 26	-10.28%
May 26	-10.18%
May 26	-10.14%
Apr 26	-10.08%
Apr 26	-9.52%
Apr 26	-9.45%
Apr 26	-10.03%
Mar 26	-11.2%
Mar 26	-9.94%
Mar 26	-10.17%
Mar 26	-9.9%
Feb 26	-9.75%
Feb 26	-9.44%
Feb 26	-9.77%
Feb 26	-9.49%
Jan 26	-9.31%
Jan 26	-9.53%
Jan 26	-10.38%
Jan 26	-9.02%
Jan 26	-9.16%
Dec 25	-8.98%
Dec 25	-8.99%
Dec 25	-8.86%
Dec 25	-9.54%
Nov 25	-9.42%
Nov 25	-9.89%
Nov 25	-9.74%
Nov 25	-10.13%
Oct 25	-9.7%
Oct 25	-9.64%
Oct 25	-9.46%
Oct 25	-9.79%
Oct 25	-10.34%
Sep 25	-9.94%
Sep 25	-10.47%
Sep 25	-9.97%
Sep 25	-10.91%
Aug 25	-10.65%
Aug 25	-10.1%
Aug 25	-9.82%
Aug 25	-9.88%
Aug 25	-9.94%
Jul 25	-9.06%
Jul 25	-9%
Jul 25	-9.19%
Jul 25	-9.52%
Jun 25	-9.56%
Jun 25	-9.65%
Jun 25	-9.02%
Jun 25	-8.52%
May 25	-8.39%
May 25	-9.04%
May 25	-8.73%
May 25	-10.2%
May 25	-10.36%
Apr 25	-9.89%
Apr 25	-10.45%
Apr 25	-10.92%
Apr 25	-11.94%
Mar 25	-11.21%
Mar 25	-10.99%
Mar 25	-10.67%
Mar 25	-11.69%
Feb 25	-11.92%
Feb 25	-11.19%
Feb 25	-10.55%
Feb 25	-10.91%
Jan 25	-10.11%
Jan 25	-9.98%
Jan 25	-11.22%
Jan 25	-11.83%
Jan 25	-11%
Dec 24	-11.18%
Dec 24	-12%
Dec 24	-11.44%
Dec 24	-11.66%
Nov 24	-11.33%
Nov 24	-13.59%
Nov 24	-14%
Nov 24	-12.96%
Nov 24	-12.19%
Oct 24	-12.82%
Oct 24	-12.74%

Price to Sales

MDWD Price to Sales by quarter
Period	Price to Sales
Sep 26	14.24
Sep 26	14.43
Aug 26	13.75
Aug 26	14.35
Aug 26	14.73
Aug 26	12.79
Jul 26	12.55
Jul 26	12.65
Jul 26	12.99
Jul 26	12.71
Jul 26	13.48
Jun 26	13.51
Jun 26	12.66
Jun 26	12.64
Jun 26	12.61
May 26	10.84
May 26	12.54
May 26	12.41
May 26	12.53
May 26	12.58
Apr 26	12.64
Apr 26	13.4
Apr 26	13.5
Apr 26	12.71
Mar 26	11.38
Mar 26	12.83
Mar 26	12.54
Mar 26	12.88
Feb 26	9.11
Feb 26	9.41
Feb 26	9.09
Feb 26	9.37
Jan 26	9.55
Jan 26	9.32
Jan 26	8.56
Jan 26	9.85
Jan 26	9.7
Dec 25	9.89
Dec 25	9.88
Dec 25	10.03
Dec 25	9.31
Nov 25	9.44
Nov 25	8.98
Nov 25	9.96
Nov 25	9.58
Oct 25	10
Oct 25	10.06
Oct 25	10.26
Oct 25	9.91
Oct 25	9.38
Sep 25	9.76
Sep 25	9.26
Sep 25	9.73
Sep 25	8.89
Aug 25	9.11
Aug 25	9.61
Aug 25	9.88
Aug 25	10.06
Aug 25	10
Jul 25	10.98
Jul 25	11.05
Jul 25	10.81
Jul 25	10.44
Jun 25	10.4
Jun 25	10.31
Jun 25	11.02
Jun 25	11.66
May 25	11.85
May 25	11
May 25	10.93
May 25	9.35
May 25	9.21
Apr 25	9.65
Apr 25	9.13
Apr 25	8.74
Apr 25	7.99
Mar 25	8.51
Mar 25	8.68
Mar 25	9.88
Mar 25	9.02
Feb 25	8.85
Feb 25	9.42
Feb 25	10
Feb 25	9.66
Jan 25	10.44
Jan 25	10.57
Jan 25	9.4
Jan 25	8.91
Jan 25	9.59
Dec 24	9.43
Dec 24	8.79
Dec 24	9.22
Dec 24	9.05
Nov 24	9.31
Nov 24	7.59
Nov 24	7.37
Nov 24	7.97
Nov 24	8.46
Oct 24	8.05
Oct 24	8.1

EV/EBITDA

MDWD EV/EBITDA by quarter
Period	EV/EBITDA
Aug 24	53.53
Aug 24	51.5
Jul 24	59.74
Jul 24	55.48
Jul 24	64.58
Jul 24	59.03
Jun 24	44.54
Jun 24	37.22
Jun 24	42.62
Jun 24	49.94
May 24	47.34
May 24	44.93
May 24	47.04
May 24	48.26
May 24	53.01
Apr 24	51.54
Apr 24	42.72
Apr 24	43.5
Apr 24	40.36
Mar 24	37.28
Mar 24	43.43
Jul 20	14.14
Jul 20	15.14
Jul 20	12.96
Jul 20	12.25
Jul 20	11.54
Jun 20	8.27
Jun 20	8.46
Jun 20	4.67
Jun 20	5.45
May 20	5.29
May 20	5.14
May 20	6
May 20	6.25
May 20	6.45
Apr 20	5.8
Apr 20	6.38
Apr 20	3.87
Apr 20	2.99
Mar 20	4.18
Mar 20	3.8
Mar 20	7.16
Mar 20	9.49
Feb 20	11.43
Feb 20	3.91
Feb 20	3.88
Feb 20	3.95
Jan 20	4.01
Jan 20	4.05
Jan 20	4.01
Jan 20	4.01
Jan 20	4.05
Dec 19	3.99
Dec 19	4.02
Dec 19	4.16
Dec 19	3.65
Nov 19	3.93
Nov 19	3.95
Nov 19	4.05
Nov 19	3.42
Nov 19	3.25
Oct 19	2.96
Oct 19	3.01
Oct 19	3.38
Oct 19	3.44
Sep 19	3.59
Sep 19	4.04
Sep 19	3.85
Sep 19	3.5
Aug 19	3.73
Aug 19	3.44
Aug 19	2.82

Price/Operating Cashflow

MDWD Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Jul 20	13.66
Jul 20	14.39
Jul 20	12.78
Jul 20	12.26
Jul 20	11.74
Jun 20	9.34
Jun 20	9.47
Jun 20	6.69
Jun 20	7.27
May 20	7.14
May 20	7.04
May 20	6.75
May 20	6.89
May 20	7
Apr 20	6.65
Apr 20	6.96
Apr 20	5.6
Apr 20	5.13
Mar 20	5.77
Mar 20	5.56
Mar 20	7.38
Mar 20	8.64
Feb 20	9.69
Feb 20	9.39
Feb 20	9.36
Feb 20	9.45
Jan 20	9.54
Jan 20	9.61
Jan 20	9.54
Jan 20	9.54
Jan 20	9.61
Dec 19	9.51
Dec 19	9.55
Dec 19	9.76
Dec 19	9.01
Nov 19	9.42
Nov 19	9.45
Nov 19	9.61
Nov 19	6.75
Nov 19	6.57
Oct 19	6.25
Oct 19	6.3
Oct 19	6.7
Oct 19	6.77
Sep 19	6.94
Sep 19	7.42
Sep 19	7.22
Sep 19	6.84
Aug 19	7.08
Aug 19	6.77
Aug 19	6.1

Price to Book

MDWD Price to Book by quarter
Period	Price to Book
Sep 26	4.74
Sep 26	4.8
Aug 26	4.58
Aug 26	4.77
Aug 26	4.9
Aug 26	4.47
Jul 26	4.39
Jul 26	4.42
Jul 26	4.54
Jul 26	4.44
Jul 26	4.71
Jun 26	4.72
Jun 26	4.43
Jun 26	4.42
Jun 26	4.41
May 26	4.21
May 26	4.87
May 26	4.82
May 26	4.87
May 26	4.89
Apr 26	4.91
Apr 26	5.21
Apr 26	5.25
Apr 26	4.94
Mar 26	4.42
Mar 26	4.99
Mar 26	4.87
Mar 26	5.01
Feb 26	3.8
Feb 26	3.93
Feb 26	3.8
Feb 26	3.91
Jan 26	3.98
Jan 26	3.89
Jan 26	3.57
Jan 26	4.11
Jan 26	4.05
Dec 25	4.13
Dec 25	4.12
Dec 25	4.19
Dec 25	3.89
Nov 25	3.94
Nov 25	3.75
Nov 25	9.83
Nov 25	9.46
Oct 25	9.87
Oct 25	9.93
Oct 25	10.12
Oct 25	9.79
Oct 25	9.26
Sep 25	9.63
Sep 25	9.14
Sep 25	9.61
Sep 25	8.77
Aug 25	8.99
Aug 25	9.48
Aug 25	9.75
Aug 25	6.18
Aug 25	6.15
Jul 25	6.74
Jul 25	6.79
Jul 25	6.64
Jul 25	6.41
Jun 25	6.39
Jun 25	6.33
Jun 25	6.77
Jun 25	7.16
May 25	7.28
May 25	6.76
May 25	7.09
May 25	6.07
May 25	5.98
Apr 25	6.26
Apr 25	5.92
Apr 25	5.67
Apr 25	5.19
Mar 25	5.52
Mar 25	5.64
Mar 25	5.69
Mar 25	5.2
Feb 25	5.1
Feb 25	5.43
Feb 25	5.76
Feb 25	5.57
Jan 25	6.01
Jan 25	6.09
Jan 25	5.42
Jan 25	5.13
Jan 25	5.52
Dec 24	5.43
Dec 24	5.06
Dec 24	5.31
Dec 24	5.21
Nov 24	5.36
Nov 24	8.56
Nov 24	8.31
Nov 24	8.98
Nov 24	9.54
Oct 24	9.08
Oct 24	9.13

No video analysis for this stock yet. Request one from our team.

News: MDWD

globenewswire.com · 2 Sep 2026

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

MediWound to Present at the H.C. Wainwright 28 th Annual Global Investment Conference YAVNE, Israel, September 2, 2026 -- MediWound Ltd.

seekingalpha.com · 13 Aug 2026

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

marketbeat.com · 13 Aug 2026

MediWound Q2 Earnings Call Highlights

MediWound NASDAQ: MDWD reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million a year earlier, as the company continued investing in its Phase III EscharEx chronic-wound program and expanded development work around its NexoBrid burn treatment.

zacks.com · 13 Aug 2026

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates

MediWound (MDWD) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $1.23 per share a year ago.

globenewswire.com · 13 Aug 2026

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid ® Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed Conference Call Today at 8:30 a.m. Eastern Time YAVNE, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd.

globenewswire.com · 29 Jul 2026

MediWound to Report Second Quarter 2026 Financial Results

MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd.